Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Free Subscription


1 Arch Virol
1 BMC Gastroenterol
1 Eur J Gastroenterol Hepatol
1 Hepatology
1 J Infect Dis
2 J Med Virol
8 J Viral Hepat
1 Lancet Gastroenterol Hepatol
3 PLoS One
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arch Virol

  1. LI Y, Shen C, Yang L, Yang Y, et al
    Correction to: Intra-host diversity of hepatitis B virus during mother-to-child transmission: the X gene may play a key role in virus survival in children after transmission.
    Arch Virol. 2020 May 6. pii: 10.1007/s00705-020-04636.
    PubMed         Abstract available

    BMC Gastroenterol

  2. ALLARD NL, MacLachlan JH, Dev A, Dwyer J, et al
    Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes.
    BMC Gastroenterol. 2020;20:140.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  3. TSAI MC, Chang KC, Yen YH, Wu CK, et al
    Comparison of tenofovir and entecavir in the development of acute kidney injury in cirrhotic chronic hepatitis B patients with refractory ascites.
    Eur J Gastroenterol Hepatol. 2020 May 2. doi: 10.1097/MEG.0000000000001711.
    PubMed         Abstract available


  4. LIGAT G, Schuster C, Baumert TF
    HBV core variants, liver fibrosis and hepatocellular carcinoma.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30231.
    PubMed         Abstract available

    Int J STD AIDS

  5. BANERJEE P, Madhwapathi V, Thorley N, Radcliffe K, et al
    A service evaluation comparing home-based testing to clinic-based testing for HIV, syphilis and hepatitis B in Birmingham and Solihull.
    Int J STD AIDS. 2020 May 4:956462419900461. doi: 10.1177/0956462419900461.
    PubMed         Abstract available

    J Infect Dis

  6. DASGUPTA S, Imamura M, Gorstein E, Nakahara T, et al
    Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration.
    J Infect Dis. 2020 May 4. pii: 5828592. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  7. WATANABE T, Tokumoto Y, Joko K, Michitaka K, et al
    Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25984.
    PubMed         Abstract available

  8. AMSTUTZ A, Nsakala BL, Cheleboi M, Lejone TI, et al
    Low rates of active hepatitis B and C infections among adults and children living with HIV and taking antiretroviral therapy: a multicenter screening study in Lesotho.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25970.
    PubMed         Abstract available

    J Viral Hepat

  9. ZHANG M, O'Keefe D, Iwamoto M, Sann K, et al
    High sustained viral response rate in patients with hepatitis C using generic sofosbuvir and daclatasvir in Phnom Penh, Cambodia.
    J Viral Hepat. 2020 May 2. doi: 10.1111/jvh.13311.
    PubMed         Abstract available

  10. PAN YC, Jia ZF, Wang YQ, Yang N, et al
    The role of cesarean section and non-breastfeeding in preventing mother-to-child transmission of hepatitis B virus in HBsAg and HBeAg positive mothers: results from a prospective cohort study and a meta-analysis.
    J Viral Hepat. 2020 May 3. doi: 10.1111/jvh.13314.
    PubMed         Abstract available

  11. LEE WM, King WC, Schwarz KB, Rule J, et al
    Prevalence and Clinical Features of Patients with Concurrent HBsAg and Anti-HBs: Evaluation of the Hepatitis B Research Network Cohort.
    J Viral Hepat. 2020 May 4. doi: 10.1111/jvh.13312.
    PubMed         Abstract available

  12. JEON MY, Lee JS, Lee HW, Kim BK, et al
    Entecavirandtenofoviron renal function in patients with hepatitis B virus related hepatocellular carcinoma.
    J Viral Hepat. 2020 May 4. doi: 10.1111/jvh.13313.
    PubMed         Abstract available

  13. LIM TS, Lee HW, Lee JI, Kim IH, et al
    Predictive score for hepatocellular carcinoma after hepatitis B eantigen loss in patients treated with entecavir or tenofovir.
    J Viral Hepat. 2020 May 7. doi: 10.1111/jvh.13316.
    PubMed         Abstract available

  14. YUEN L, Revill PA, Rosenberg G, Wagner J, et al
    HBV variants are common in the "immune-tolerant"phase of chronic hepatitis B.
    J Viral Hepat. 2020 May 8. doi: 10.1111/jvh.13318.
    PubMed         Abstract available

  15. NING G, Zhen LM, Xu WX, Li XJ, et al
    Suppression of complement component2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients.
    J Viral Hepat. 2020 May 8. doi: 10.1111/jvh.13319.
    PubMed         Abstract available

  16. LI MR, Xu ZG, Lu JH, Zheng HW, et al
    Clinical Features of Hepatitis B Patients at Immune-tolerance Phase with Basal Core Promoter and/or Precore Mutations.
    J Viral Hepat. 2020 May 8. doi: 10.1111/jvh.13315.
    PubMed         Abstract available

    Lancet Gastroenterol Hepatol

  17. FLEMMING JA, Dewit Y, Mah JM, Saperia J, et al
    Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study.
    Lancet Gastroenterol Hepatol. 2018 Dec 17. pii: S2468-1253(18)30339.
    PubMed         Abstract available

    PLoS One

  18. BANCHA B, Kinfe AA, Chanko KP, Workie SB, et al
    Prevalence of hepatitis B viruses and associated factors among pregnant women attending antenatal clinics in public hospitals of Wolaita Zone, South Ethiopia.
    PLoS One. 2020;15:e0232653.
    PubMed         Abstract available

  19. PIECHA F, Ganssler JM, Ozga AK, Wehmeyer MH, et al
    Treatment and re-treatment results of HCV patients in the DAA era.
    PLoS One. 2020;15:e0232773.
    PubMed         Abstract available

  20. PHILIP G, Djerboua M, Carlone D, Flemming JA, et al
    Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data.
    PLoS One. 2020;15:e0229218.
    PubMed         Abstract available


  21. NAKASONE M, Lopes MH, Sartori AMC, Sandoval EPN, et al
    Immunogenicity, long term protection and safety of subcutaneous administration of hepatitis A vaccine in patients with hemophilia and other bleeding disorders: A randomized study.
    Vaccine. 2020 May 3. pii: S0264-410X(20)30533.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.